Lithium Australia NL’s (ASX:LIT) LieNA® is a caustic conversion process that recovers lithium from fine and low-quality spodumene that otherwise is considered as waste streams. It improves the sustainability of lithium production.
The company is negotiating with spodumene concentrate producers and lithium chemical manufacturers who understand the potential of LieNA® upon commercialisation.
Lithium Australia is planning to seek formal expressions of interest to participate in its pilot-plant programme in return for equity in the process.
LIT's refining technology offers a direct feed for lithium-Ferro-phosphate ('LFP') batteries production.
There is no one left untouched by the charm of the multibillion-dollar global boom in cannabis. Its glorious journey from a criminalized drug to being used in over 20 countries for treating medical conditions.
No wonder the cannabis stocks are on the edge of a green rush. Don’t miss out on the happenings in the cannabis sector and take advantage of the growth phase of this sector by subscribing to our report on Marijuana stocks in Australia.
Find out the drivers for the rise in cannabis stock rates Even though the cannabis sector is in its growing phase, Australian cannabis stocks have already started to rise actively due to a hastily increasing patient base, and a legislative landscape that is gradually beginning to liberalise.
Outreach and future of cannabis stocks As countries liberalise regulation for medical and recreational use of cannabis, it is predicted that the industry would grow sharply in upcoming years The global cannabis market stands currently at around $8 billion and it is expected that the hemp derived CBD market to hit approximately $22 billion by 2022.
Key Players in the sector Althea Group Holdings Limited (ASX: AGH) and Cann Group Limited (ASX: CAN) are amongst the top players. Other Australia cannabis market players are- MGC Pharmaceuticals Ltd (ASX: MXC), Elixinol Global Limited (ASX: EXL), THC Global Group Limited (ASX: THC), AusCann Group Holdings Limited (ASX: AC8)